Andrew Bauerschmidt

Dr. Andrew Bauerschmidt

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2023 in Current Neurology and Neuroscience Reports
Verified
Journal Article
Closed access
PDF file
ABAndrew Bauerschmidt
Andrew Bauerschmidt
TATarik Al-Bermani
Tarik Al-Bermani
SASyed Ali
Syed Ali
BBBrittany Bass
Brittany Bass
JDJessica Dorilio
Jessica Dorilio
FAFawaz Al-Mufti
Fawaz Al-Mufti

1 August 2021 in Resuscitation
Verified
Journal Article
Closed access
ABAndrew Bauerschmidt
Andrew Bauerschmidt
AEAndrey Eliseyev
Andrey Eliseyev
KDKevin W. Doyle
Kevin W. Doyle
AVAngela Velasquez
Angela Velasquez
JEJennifer Egbebike
Jennifer Egbebike
JCJan Claassen
Jan Claassen

2 March 2022 in Interventional Neuroradiology
Verified
Journal Article
Closed access
EFEric Feldstein
Eric Feldstein
SASyed Ali
Syed Ali
SPSmit Patel
Smit Patel
KRKeshav Raghavendran
Keshav Raghavendran
EMErick Martinez
Erick Martinez
FAFawaz Al-Mufti
Fawaz Al-Mufti
Introduction: Acute respiratory distress syndrome (ARDS) is a known predictor of poor outcomes in critically ill patients. We sought to examine the role ARDS plays in outcomes in subarachnoid hemorrhage (SAH) patients. Prior studies investigating the incidence of ARDS in SAH patients did not control for SAH severity. Hence, we sought to determine the incidence ARDS in patients diagnosed with aneurysmal SAH and investigate the predisposing risk factors and impact upon outcomes. Methods: A retrospective cohort study was conducted using the National Inpatient Sample (NIS) database for the years 2008 to 2014. Multivariate stepwise regression analysis was performed to identify the risk factors and outcome associated with developing ARDS in the setting of SAH. Results: We identified 170,869 patients with non-traumatic subarachnoid hemorrhage, of whom 6962 were diagnosed with ARDS and of those 4829 required mechanical ventilation. ARDS more frequently developed in high grade SAH patients (1.97 ± 0.05 vs. 1.15 ± 0.01; p < 0.0001). Neurologic predictors of ARDS included cerebral edema (OR 1.892, CI 1.180–3.034, p = 0.0035) and medical predictors included cardiac arrest (OR 4.642, CI 2.273–9.482, p < 0.0001) and cardiogenic shock (OR 2.984, CI 1.157–7.696, p = 0.0239). ARDS was associated with significantly worse outcomes (15.5% vs. 52.9% discharged home, 63.0% vs. 40.8% discharged to rehabilitation facility and 21.5% vs. 6.3% in-hospital mortality). Conclusion: Patients with SAH who developed ARDS were less likely to be discharged home, more likely to need rehabilitation and had a significantly higher risk of mortality. The identification of risk factors contributing to ARDS is helpful for improving outcomes and resource utilization.

2 July 2024 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
GSGaladu Subah
Galadu Subah
RPRohan N Patel
Rohan N Patel
BNBridget Nolan
Bridget Nolan
MFMichael Peter Fortunato
Michael Peter Fortunato
ALAiden Lui
Aiden Lui
FAFawaz Al-Mufti
Fawaz Al-Mufti

28 November 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
HNHelen Ng
Helen Ng
EHEllen Nicole Huhulea
Ellen Nicole Huhulea
AJAnkita Jain
Ankita Jain
MFMichael Fortunato
Michael Fortunato
GSGaladu Subah
Galadu Subah
FAFawaz Al-Mufti
Fawaz Al-Mufti
Background/Objectives: Recent studies reveal an “obesity paradox”, suggesting better clinical outcomes after intracranial hemorrhage for obese patients compared to patients with a healthy BMI. While this paradox indicates improved survival rates for obese individuals in stroke cases, it is unknown whether this trend remains true across all forms of intracranial hemorrhage. Therefore, the objective of our study was to investigate the incidence, characteristics, and outcomes of hospitalized obese patients with intracranial hemorrhage. Methods: The National Inpatient Sample (NIS) database was queried for data from 2015 to 2019 to identify adult patients aged 18 years and older with a primary diagnosis of non-traumatic intracranial hemorrhage. Using International Classification of Disease 10th Edition codes, patients were stratified by BMI categories: healthy weight, overweight, class I–II obesity, and class III obesity. The cohorts were examined for demographic characteristics, comorbidities, stroke severity, inpatient complications, interventions, and clinical outcomes, including length of stay (LOS), discharge disposition, and inpatient mortality. Results: Of 41,960 intracranial hemorrhage patients identified, 13,380 (33.0%) also had an obese BMI. Class I–II obese intracranial hemorrhage patients were more likely to be of white race (OR: 1.101, 95% CI: 1.052, 1.152, p < 0.001), less likely to be female (OR: 0.773, 95% CI: 0.740, 0.808, p < 0.001), and more likely to have diabetes mellitus (OR: 1.545, 95% CI: 1.477, 1.616, p < 0.001) and hypertension (OR: 1.828, 95% CI: 1.721, 1.943, p < 0.001) in comparison to healthy-weight patients. In a matched cohort analysis adjusting for demographics and severity, intracranial hemorrhage patients with class I–II obesity had a shorter length of stay (LOS) (OR 0.402, 95% CI: 0.118, 0.705, p < 0.001), reduced inpatient mortality (OR 0.847, 95% CI: 0.798, 0.898, p < 0.001), and more favorable discharge disposition (OR 1.395, 95% CI: 1.321, 1.474, p < 0.001) compared to their healthy-weight counterparts. Furthermore, these patients were less likely to require decompressive hemicraniectomy (OR 0.697, 95% CI: 0.593, 0.820, p < 0.001). Following an analysis of individual ICH subtypes, obese subarachnoid hemorrhage (SAH) patients demonstrated reduced mortality (OR: 0.692, 95% CI: 0.577–0.831, p < 0.001) and LOS (OR: 0.070, 95% CI: 0.466–0.660, p = 0.039), with no differences in discharge disposition. Similarly, intracerebral hemorrhage patients demonstrated reduced mortality (OR: 0.891, 95% CI: 0.827–0.959, p = 0.002) and LOS (OR: 0.480, 95% CI: 0.216–0.743, p < 0.001). Other ICH subtypes showed improved discharge outcomes (OR: 1.504, 95% CI: 1.368–1.654, p < 0.001), along with decreased mortality (OR: 0.805, 95% CI: 0.715–0.907, p < 0.001) and LOS (OR: −10.313, 95% CI: −3.599 to −2.449, p < 0.001). Conclusions: Intracranial hemorrhage patients with class I–II obesity exhibited more favorable clinical outcomes than those who were of a healthy weight or overweight. Despite its association with risk factors contributing to intracranial hemorrhage, class I–II obesity was associated with improved outcomes, lending support to the existence of the obesity paradox in stroke.

3 February 2022 in Interventional Neuroradiology
Verified
Journal Article
Closed access
CNChristina Ng
Christina Ng
JDJose F Dominguez
Jose F Dominguez
RHRasheed Hosein-Woodley
Rasheed Hosein-Woodley
EFEric Feldstein
Eric Feldstein
ANAlexandria Naftchi
Alexandria Naftchi
FAFawaz Al-Mufti
Fawaz Al-Mufti
Introduction: Acute kidney injury (AKI) is associated with poor outcome in aneurysmal subarachnoid hemorrhage patients (aSAH). Frailty has recently been demonstrated to correlate with elevated mortality and morbidity; its impact on predicting AKI and mortality in aSAH patients has not been investigated. Objective: Evaluating risk factors and predictors for AKI in aSAH patients. Methods: aSAH patients from a single-center's prospectively maintained database were retrospectively evaluated for development of AKI within 14 days of admission. Baseline demographic and clinical characteristics were collected. The effect of frailty and other risk factors were evaluated. Results: Of 213 aSAH patients, 53 (33.1%) were frail and 12 (5.6%) developed AKI. Admission serum creatinine (sCr) and peak sCr within 48 h were higher in frail patients. AKI patients showed a trend towards higher frailty. Mortality was significantly higher in AKI than non-AKI aSAH patients. Frailty was a poor predictor of AKI when controlling for Hunt and Hess (HH) grade or age. HH grade ≥ 4 strongly predicted AKI when controlling for frailty. Conclusion: AKI in aSAH patients carries a poor prognosis. The HH grade appears to have superior utility as a predictor of AKI in aSAH patients than mFI.